Skip to main content
. 2022 May 4;189(5):212. doi: 10.1007/s00604-022-05283-9

Fig. 5.

Fig. 5

Clinical sample feasibility verification. Ten positive samples of HPV-6 were randomly selected for nano-LAMP and conventional LAMP. (A) Images of pre-reactions for conventional LAMP reactions added MNPs and post-reaction images and for nano-LAMP after magnetic separation (B). (C) Gel electrophoresis images of conventional LAMP products and gel electrophoresis images of nano-LAMP products (D). (E) Results of cross-reaction validation of clinical samples: Primers of HPV-6 were reacted with clinical samples (HPV-6, HPV-11, HPV-16, and HPV-42–44) for conventional LAMP (F) and nano-LAMP (G)